Psychotomimesis Mediated by κ Opiate Receptors
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The κ opioid agonists are analgesics that seem to be free of undesired morphine-like effects. Their dysphoric actions observed with the κ agonist cyclazocine are thought to be mediated by an action at σ-phencyclidine receptors. The benzomorphan κ agonist MR 2033 is inactive at σ-phencyclidine receptors. In male subjects, the opiate-active (-)-isomer, but not the (+)-isomer, elicited dose-dependent dysphoric and psychotomimetic effects that were antagonized by naloxone. Thus, κ opiate receptors seem to mediate psychotomimetic effects. In view of the euphorigenic properties of μ agonists, our results imply the existence of opposed opioid systems affecting emotional and perceptual experiences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“agonism of κ-opioid receptors were shown to produce depression-like symptoms in humans (Pfeiffer et al., 1986).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pfeiffer et al., 1986
In the citing paper
“Nonetheless, the three receptor types have different behavioral domains, with MOR and DOR mediating generally positive motivation and affect, while KOR mediates generally negative motivation and aversion (Pfeiffer et al 1986; Shippenberg et al 1987; Pecina and Berridge 2000; McLaughlin et al 2003; for reviews see Van Ree et al 2000; Le Merrer et al 2009).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Pfeiffer et al 1986
In the citing paper
“Kappa receptor agonists induce anxiogenic and dysphoric effects in humans (141-143) and depressive-like behavior in animals (i.e., increased immobility in the forced swim test) (144, 145).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [141]
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man
Domino, E. F., Chodoff, P., & Corssen, G. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563279 · Cited by 748
Martin, W. R. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06637-2 · Cited by 648
Thrills in response to music and other stimuli
Goldstein, A. (1980) · Physiological Psychology · doi:10.3758/bf03326460 · Cited by 522
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Self-citationThe binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties
Magnan, J., Paterson, S. J., Tavani, A., & Kosterlitz, H. W. (1982) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00495865 · Cited by 509
A CLASSIFICATION OF OPIATE RECEPTORS THAT MEDIATE ANTINOCICEPTION IN ANIMALS
TYERS, M. B. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb07041.x · Cited by 341
Opiate receptor binding sites in human brain
Pfeiffer, A., Pasi, A., Mehraein, P., & Herz, A. (1982) · Brain Research · doi:10.1016/0006-8993(82)91150-7 · Cited by 298
Self-citationPhencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film.
Quirion, R., Hammer, R. P., Herkenham, M., & Pert, C. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5881 · Cited by 254
Research works printed but not linked: 6
- Jasinski, D. R., Drug Addiction 1: 216 (1977).
- MARTIN, W.R., PHARMACOL REV 35: 283 (1984).
- MARTIN, W.R., SUBSTANCE AND ALCOHOL ACTIONS/MISUSE 1: 269 (1980).
- Shearman, G. T., Drug Discrimination: Application in CNS Pharmacology: 37 (1982).
- VAUPEL, D.B., FAILURE OF NALTREXONE (NTX) TO ANTAGONIZE PHENCYCLIDINE (PCP) AND THE OPIOID SKF-10047 (SKF) IN THE DOG, FEDERATION PROCEEDINGS 41: 1333 (1982).
- Zerssen, D. V., Assessment of Depression: 270 (1985).
Cited by
Items 201–300 of 956
Sex differences in kappa opioid pharmacology
Rasakham, K., & Liu-Chen, L.-Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2010.10.007 · Cited by 83
Koob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 87
Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze
Privette, T. H., & Terrian, D. M. (1995) · Psychopharmacology · doi:10.1007/bf02245945 · Cited by 87
New Pharmacological Treatment Strategies for Relapse Prevention
Spanagel, R., & Vengeliene, V. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_205 · Cited by 86
A systems medicine research approach for studying alcohol addiction
Spanagel, R., Durstewitz, D., Hansson, A., Heinz, A., Kiefer, F., Köhr, G., Matthäus, F., Nöthen, M. M., Noori, H. R., Obermayer, K., et al. (2013) · Addiction Biology · doi:10.1111/adb.12109 · Cited by 81
A Novel Method for Analyzing Extremely Biased Agonism at G Protein–Coupled Receptors
Stahl, E. L., Zhou, L., Ehlert, F. J., & Bohn, L. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096503 · Cited by 86
Mitch, C. H., Quimby, S. J., Diaz, N., Pedregal, C., de la Torre, M. G., Jimenez, A., Shi, Q., Canada, E. J., Kahl, S. D., Statnick, M. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200789r · Cited by 86
Negus, S. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1878-7 · Cited by 86
Abraham, A. D., Schattauer, S. S., Reichard, K. L., Cohen, J. H., Fontaine, H. M., Song, A. J., Johnson, S. D., Land, B. B., & Chavkin, C. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0653-18.2018 · Cited by 84
Use patterns and self-reported effects of Salvia divinorum: An internet-based survey
Baggott, M. J., Erowid, E., Erowid, F., Galloway, G. P., & Mendelson, J. E. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.003 · Cited by 84
Loth, M. K., & Donaldson, Z. R. (2021) · Endocrinology · doi:10.1210/endocr/bqaa223 · Cited by 74
Queffélec, C., Pati, P. B., & Pellegrin, Y. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00543 · Cited by 83
Analgesia and Abuse Potential: An Accidental Association or a Common Substrate?
Franklin, K. B. J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00535-2 · Cited by 83
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Kappa receptors mediate the peripheral aversive effects of opiates
Bechara, A., & van der Kooy, D. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90219-x · Cited by 81
Schmidt, M. S., Prisinzano, T. E., Tidgewell, K. J., Harding, W. W., Butelman, E. R., Kreek, M. J., & Murry, D. J. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.12.041 · Cited by 80
Hurd, Y. L., Svensson, P., & Pontén, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09285.x · Cited by 80
Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors
Hallberg, M. (2014) · Medicinal Research Reviews · doi:10.1002/med.21323 · Cited by 79
Burns, J. A., Kroll, D. S., Feldman, D. E., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00626 · Cited by 78
Salvinorin A: A novel and highly selective κ-opioid receptor agonist
Yan, F., & Roth, B. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.07.008 · Cited by 78
Kappa opioid receptor and dynorphin signaling in the central amygdala regulates alcohol intake
Bloodgood, D. W., Hardaway, J. A., Stanhope, C. M., Pati, D., Pina, M. M., Neira, S., Desai, S., Boyt, K. M., Palmiter, R. D., & Kash, T. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0690-z · Cited by 78
Hurd, Y. L. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000930 · Cited by 77
Roles of Nucleus Accumbens CREB and Dynorphin in Dysregulation of Motivation
Muschamp, J. W., & Carlezon, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012005 · Cited by 70
Bowen, C. A., Negus, S. S., Zong, R., Neumeyer, J. L., Bidlack, J. M., & Mello, N. K. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300105 · Cited by 77
Bjørnebekk, A., Mathé, A. A., & Brené, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300820 · Cited by 77
Gehrke, B. J., Chefer, V. I., & Shippenberg, T. S. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1067-6 · Cited by 76
Chartoff, E. H., Potter, D. N., Damez-Werno, D. M., Cohen, B. M., & Carlezon, W. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301659 · Cited by 76
New Technologies for Elucidating Opioid Receptor Function
Bruchas, M. R., & Roth, B. L. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.001 · Cited by 76
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Jacobson, M. L., Browne, C. A., & Lucki, I. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023317 · Cited by 76
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75
Mu/kappa opioid interactions in rhesus monkeys: Implications for analgesia and abuse liability.
Negus, S. S., Schrode, K. M., & Stevenson, G. W. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0013088 · Cited by 75
Berger, A. L., Williams, A. M., McGinnis, M. M., & Walker, B. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.229 · Cited by 75
Robles, C. F., McMackin, M. Z., Campi, K. L., Doig, I. E., Takahashi, E. Y., Pride, M. C., & Trainor, B. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.003 · Cited by 65
Lee, D. Y. W., Ma, Z., Liu‐Chen, L., Wang, Y., Chen, Y., Carlezon, W. A., & Cohen, B. M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.054 · Cited by 75
Shippenberg, T. S., Stein, C., Huber, A., Millan, M. J., & Herz, A. (1988) · Pain · doi:10.1016/0304-3959(88)90225-4 · Cited by 71
Self-citationThe antinociceptive effect of Salvinorin A in mice
John, T. F., French, L. G., & Erlichman, J. S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.077 · Cited by 75
Salvinorin A Analogs and Other Kappa-Opioid Receptor Compounds as Treatments for Cocaine Abuse
Kivell, B. M., Ewald, A. W. M., & Prisinzano, T. E. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00012-3 · Cited by 74
Acute and post-acute behavioral and psychological effects of salvinorin A in humans
Addy, P. H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2470-6 · Cited by 74
Lovell, K. M., Frankowski, K. J., Stahl, E. L., Slauson, S. R., Yoo, E., Prisinzano, T. E., Aubé, J., & Bohn, L. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00092 · Cited by 74
Clark, S. D., & Abi‐Dargham, A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.012 · Cited by 74
Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system
Sirohi, S., Bakalkin, G., & Walker, B. M. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00095 · Cited by 64
Suzuki, T., Narita, M., Takahashi, Y., Misawa, M., & Nagase, H. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90237-x · Cited by 73
Donahue, R. J., Landino, S. M., Golden, S. A., Carroll, F. I., Russo, S. J., & Carlezon, W. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000155 · Cited by 72
Béguin, C., Richards, M. R., Li, J.-G., Wang, Y., Xu, W., Liu‐Chen, L., Carlezon, W. A., & Cohen, B. M. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.093 · Cited by 72
Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2)
Béguin, C., Richards, M. R., Wang, Y., Chen, Y., Liu‐Chen, L., Ma, Z., Lee, D. Y. W., Carlezon, W. A., & Cohen, B. M. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.113 · Cited by 72
Gillis, J. C., Benfield, P., & Goa, K. L. (1995) · Drugs · doi:10.2165/00003495-199550010-00010 · Cited by 72
The role of the dynorphin/κ opioid receptor system in anxiety
Hang, A., Wang, Y.-J., He, L., & Liu, J.-G. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.32 · Cited by 62
Reed, B., Butelman, E. R., Fry, R. S., Kimani, R. W., & Kreek, M. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.205 · Cited by 69
Tolerance and selective cross-tolerance to the motivational effects of opioids
Shippenberg, T. S., Emmett‐Oglesby, M. W., Ayesta, F. J. A., & Herz, A. (1988) · Psychopharmacology · doi:10.1007/bf02431542 · Cited by 69
Self-citationSubtypes of the κ-opioid receptor: fact or fiction?
Traynor, J. R. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90074-6 · Cited by 69
Veer, A. V., Bechtholt, A. J., Onvani, S., Potter, D. N., Wang, Y., Liu‐Chen, L., Schütz, G., Chartoff, E. H., Rudolph, U., Cohen, B. M., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.58 · Cited by 68
Depersonalization disorder: pharmacological approaches
Sierra, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.19 · Cited by 62
Siciliano, C. A., Calipari, E. S., Cuzon Carlson, V. C., Helms, C. M., Lovinger, D. M., Grant, K. A., & Jones, S. R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4820-14.2015 · Cited by 61
Shippenberg, T. S. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.165 · Cited by 67
Post-translational Modifications of Opioid Receptors
Duarte, M. L., & Devi, L. A. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.011 · Cited by 66
Xu, K., Seo, D., Hodgkinson, C., Hu, Y., Goldman, D., & Sinha, R. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.62 · Cited by 64
Schoffelmeer, A. N. M., Hogenboom, F., & Mulder, A. H. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701394 · Cited by 66
Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues
Lee, D. Y. W., Karnati, V. V. R., He, M., Liu‐Chen, L., Kondaveti, L., Ma, Z., Wang, Y., Chen, Y., Béguin, C., Carlezon, W. A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.048 · Cited by 66
G Protein–coupled Receptor Biased Agonism
Hodavance, S., Gareri, C., Török, R. D., & Rockman, H. A. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000356 · Cited by 65
Puryear, C. B., Brooks, J. M., Tan, L. A., Smith, K. L., Li, Y., Cunningham, J. I., Todtenkopf, M. S., Dean, R. L., & Sánchez, C. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.007 · Cited by 65
Allelic and somatic variations in the endogenous opioid system of humans
Mayer, P. E., & Höllt, V. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00154-1 · Cited by 65
Vanderah, T. W., Schteingart, C. D., Trojnar, J., Junien, J., Lai, J. Y., & Rivière, P. J.-M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065391 · Cited by 63
Schattauer, S. S., Bedini, A., Summers, F., Reilly-Treat, A., Andrews, M. M., Land, B. B., & Chavkin, C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009592 · Cited by 63
Simmen, U., Burkard, W. P., Berger, K., Schaffner, W., & Lundstrom, K. H. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036637 · Cited by 63
Rothman, R. B., France, C. P., Bykov, V., de Costa, B. R., Jacobson, A. E., Woods, J. H., & Rice, K. C. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90443-3 · Cited by 63
Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats
Grella, S. L., Funk, D. R., Coen, K., Li, Z., & Lê, A. D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.029 · Cited by 62
Heroin Addiction: Neurobiology, Pharmacology, and Policy
Goldstein, A. (1991) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1991.10472231 · Cited by 62
Váradi, A., Marrone, G. F., Eans, S. O., Ganno, M. L., Subrath, J. J., Rouzic, V. L., Hunkele, A., Pasternak, G. W., McLaughlin, J. P., & Majumdar, S. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00153 · Cited by 61
Reilley, K. J., Giulianotti, M. A., Dooley, C. T., Nefzi, A., McLaughlin, J. P., & Houghten, R. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9191-3 · Cited by 61
Wang, Y., Rasakham, K., Huang, P., Chudnovskaya, D., Cowan, A., & Liu‐Chen, L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183905 · Cited by 60
Opioid Analgesic Drugs in the Elderly
Forman, W. B. (1996) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30213-1 · Cited by 60
Ophuis, R. J. A. O., Boender, A. J., van Rozen, A. J., & Adan, R. A. H. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00014 · Cited by 59
Prisinzano, T. E. (2008) · Journal of Natural Products · doi:10.1021/np8005748 · Cited by 59
Dykstra, L. A., Preston, K. L., & Bigelow, G. E. (1997) · Psychopharmacology · doi:10.1007/s002130050208 · Cited by 59
Hughes, R. A. (1990) · Behavioral Neuroscience · doi:10.1037//0735-7044.104.4.619 · Cited by 59
Chen, C., Willhouse, A. H., Huang, P., Ko, N., Wang, Y., Xu, B., Huang, L., Kieffer, B. L., Barbe, M. F., & Liu‐Chen, L. (2020) · eNeuro · doi:10.1523/eneuro.0028-20.2020 · Cited by 58
Smith, M. A., Bryant, P. A., & McClean, J. M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00189-8 · Cited by 58
Peckys, D. B., & Hurd, Y. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00525-1 · Cited by 58
Verhoest, P. R., Basak, A. S., Parikh, V. D., Hayward, M. M., Kauffman, G. W., Paradis, V., McHardy, S. F., McLean, S., Grimwood, S., Schmidt, A. W., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2006035 · Cited by 58
Kappa Opioid Receptor Endocytosis by Dynorphin Peptides
Jordan, B. A., Cvejic, S., & Devi, L. A. (2000) · DNA and Cell Biology · doi:10.1089/104454900314672 · Cited by 58
Freeman, K. B., Naylor, J. E., Prisinzano, T. E., & Woolverton, W. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3436-2 · Cited by 60
Muschamp, J. W., Nemeth, C. L., Robison, A. J., Nestler, E. J., & Carlezon, W. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.08.011 · Cited by 46
Peripheral receptors mediate the aversive conditioning effects of morphine in the rat
Bechara, A., Zito, K. A., & van der Kooy, D. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90218-8 · Cited by 57
Noble, F., & Marie, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00742 · Cited by 56
“KOPr agonists have dysphoric and aversive effects in humans and rodents (16, 17), in good agreement with decreases in dopamine release in the Nac observed following injection of selective agonists in this brain structure (18).”
BackgroundGuillemyn, K., Starnowska-Sokół, J., Lagard, C., Dyniewicz, J., Rojewska, E., Mika, J., Chung, N. N., Utard, V., Kossoń, P., Lipkowski, A. W., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01976 · Cited by 56
Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum
Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1315-4 · Cited by 56
Rothwell, P. E., Thomas, M. J., & Gewirtz, J. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.56 · Cited by 56
Wilson, J. L., Nayanar, V., & Walker, J. S. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15601.x · Cited by 56
Li, J., Li, J.-G., Chen, C., Zhang, F., & Liu‐Chen, L. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.73 · Cited by 56
Li, J.-G., Chen, C., & Liu‐Chen, L. (2007) · Biochemistry · doi:10.1021/bi700443j · Cited by 55
Willmore, C. B., Krall, D. M., McCurdy, C. R., & Kinder, D. H. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.008 · Cited by 55
Ligand Directed Signaling Differences between Rodent and Human κ-Opioid Receptors
Schattauer, S. S., Miyatake, M., Shankar, H., Zietz, C., Levin, J. R., Liu‐Chen, L., Gurevich, V. V., Rieder, M. J., & Chavkin, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381368 · Cited by 55
Adolescent salvia substance abuse
Singh, S. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01810.x · Cited by 55
Li, J., Zhang, F., Jin, X.-L., & Liu‐Chen, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045559 · Cited by 55
Rothman, R. B., Bykov, V., Xue, B., Xu, H., de Costa, B. R., Jacobson, A. E., Rice, K. C., Kleinman, J. E., & Brady, L. S. (1992) · Peptides · doi:10.1016/0196-9781(92)90059-c · Cited by 55
Psychotropic Drugs Used in Anesthesia Practice: Abuse Liability and Epidemiology of Abuse
Zacny, J. P., & Galinkin, J. L. (1999) · Anesthesiology · doi:10.1097/00000542-199901000-00033 · Cited by 54
Béguin, C., Potter, D. N., DiNieri, J. A., Munro, T. A., Richards, M. R., Paine, T. A., Berry, L., Zhao, Z., Roth, B. L., Xu, W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129023 · Cited by 54
Mu-Opioid Receptor Selective Superagonists Produce Prolonged Respiratory Depression
Malcolm, N. J., Palkovic, B., Sprague, D. J., Calkins, M. M., Lanham, J. K., Halberstadt, A. L., Stucke, A. G., & McCorvy, J. D. (2023) · iScience · doi:10.1016/j.isci.2023.107121 · Cited by 53
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 54
Cirino, T. J., Eans, S. O., Medina, J. M., Wilson, L., Mottinelli, M., Intagliata, S., McCurdy, C. R., & McLaughlin, J. P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00678 · Cited by 53
Metadata
- Authors
- Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M.
- Affiliations
- LMU Klinikum (DE)
- Boehringer Ingelheim (Germany) (DE)
- Max Planck Society (DE)
- Max Planck Institute of Psychiatry (DE)
- ORCID
- Pfeiffer, Andreas
- Venue
- Science
- Published
- 1986-08-15
- Volume
- 233
- Issue
- 4765
- Pages
- 774-776
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2032643119
- Cited by
- 857
- References
- 30
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 23 · 2023: 17 · 2022: 18 · 2021: 38 · 2020: 42 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 37 · 2015: 38 · 2014: 30 · 2013: 35 · 2012: 41
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- psychotomimetic effects, kappa opioid receptor, kappa opioid receptor agonists, cyclazocine, naloxone antagonism, stereoisomers, mu-opioid receptor agonists, euphoria, analgesia
- MeSH terms
- Adult, Anxiety, Benzomorphans, Humans, Male, Middle Aged, Morphinans, Naloxone, Personality Tests, Phencyclidine, Receptors, Opioid, Receptors, Opioid, kappa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.